Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test.

Autor: Hoonakker ME; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands; Utrecht University, Faculty of Veterinary Medicine, Department Animals in Science and Society, Utrecht, The Netherlands. Electronic address: Marieke.Hoonakker@Intravacc.nl., Verhagen LM; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., van der Maas L; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands., Metz B; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands., Uittenbogaard JP; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands., van de Waterbeemd B; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands., van Els CA; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., van Eden W; Utrecht University, Faculty of Veterinary Medicine, Department of Infectious Diseases and Immunology, Utrecht, The Netherlands., Hendriksen CF; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands; Utrecht University, Faculty of Veterinary Medicine, Department Animals in Science and Society, Utrecht, The Netherlands., Sloots A; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands., Han WG; Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Publikováno v: Vaccine [Vaccine] 2016 Aug 17; Vol. 34 (37), pp. 4429-36. Date of Electronic Publication: 2016 Jul 21.

In vitro innate immune cell based models to assess whole cell Bordetella pertussis vaccine quality: a proof of principle.

Autor: Hoonakker ME; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands; Faculty of Veterinary Medicine, Department Animals in Science and Society, Utrecht University, The Netherlands. Electronic address: Marieke.Hoonakker@intravacc.nl., Verhagen LM; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Hendriksen CF; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands; Faculty of Veterinary Medicine, Department Animals in Science and Society, Utrecht University, The Netherlands., van Els CA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Vandebriel RJ; Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Sloots A; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands., Han WG; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Publikováno v: Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2015 Mar; Vol. 43 (2), pp. 100-9. Date of Electronic Publication: 2015 Jan 26.

Erratum: Regulatory Acceptance and Use of Serology for Inactivated Veterinary Rabies Vaccines.

Autor: Schiffelers MJ; Utrecht University School of Governance, Utrecht, The Netherlands., Blaauboer BJ; Utrecht University, Institute for Risk Assessment Sciences (IRAS), Utrecht, The Netherlands., Bakker WE; Utrecht University School of Governance, Utrecht, The Netherlands., Hendriksen CF; Institute for Translational Vaccinology (Intravacc), Bilthoven & Utrecht University, Faculty of Veterinary Medicine, Department Animals in Science and Society, The Netherlands.

Publikováno v: ALTEX [ALTEX] 2015; Vol. 32 (4), pp. 317.

Regulatory acceptance and use of 3R models for pharmaceuticals and chemicals: expert opinions on the state of affairs and the way forward.

Autor: Schiffelers MJ; Utrecht University School of Governance (USBO), Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands. Electronic address: m.j.w.a.schiffelers@uu.nl., Blaauboer BJ; Utrecht University, Institute for Risk Assessment Sciences (IRAS), P.O. Box 80.178, 3508 TD Utrecht, The Netherlands., Bakker WE; Utrecht University School of Governance (USBO), Bijlhouwerstraat 6, 3511 ZC Utrecht, The Netherlands., Beken S; Federal Agency for Medicines and Health Products (FAMHP), Victor Hortaplein 40/40, 1060 Brussels, Belgium., Hendriksen CF; Institute for Translational Vaccinology (InTraVacc), P.O. Box 450, 3720 AL Bilthoven, The Netherlands; Utrecht University, Faculty of Veterinary Medicine, Department Animals in Science and Society, P.O. Box 80.166, 3508 TD Utrecht, The Netherlands., Koëter HB; Orange House Partnership (OHP), Kampendaal 83, 1653 Dworp (Beersel), Belgium., Krul C; TNO, P.O. Box 360, 3700 AJ Zeist, The Netherlands; University of Applied Sciences Utrecht (HU), Life Sciences & Chemistry, F.C. Donderstraat 65, 3572 JE Utrecht, The Netherlands.

Publikováno v: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2014 Jun; Vol. 69 (1), pp. 41-8. Date of Electronic Publication: 2014 Feb 15.

The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test.

Autor: Hoonakker ME; Netherlands Vaccine Institute (NVI), P.O. Box 457, 3720 AL Bilthoven, The Netherlands. Marieke.Hoonakker@nvi-vaccin.nl, Ruiterkamp N, Hendriksen CF

Publikováno v: Vaccine [Vaccine] 2010 Feb 03; Vol. 28 (5), pp. 1347-52. Date of Electronic Publication: 2009 Nov 24.